Lessons learned from marketed and investigational prodrugs

J Med Chem. 2004 May 6;47(10):2393-404. doi: 10.1021/jm0303812.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / pharmacology
  • Biological Availability
  • Biological Transport
  • Carrier Proteins / metabolism
  • Drug Carriers
  • Drug Delivery Systems
  • Drug Design*
  • Drugs, Investigational* / chemistry
  • Drugs, Investigational* / pharmacokinetics
  • Drugs, Investigational* / pharmacology
  • Humans
  • Intestinal Absorption
  • Prodrugs* / chemistry
  • Prodrugs* / pharmacokinetics
  • Prodrugs* / pharmacology
  • Solubility

Substances

  • Antineoplastic Agents
  • Carrier Proteins
  • Drug Carriers
  • Drugs, Investigational
  • Prodrugs